Literature DB >> 10665469

Lifetime severity index for cocaine use disorder (LSI-Cocaine): a predictor of treatment outcomes.

Y Hser1, H Shen, C Grella, M D Anglin.   

Abstract

We developed a lifetime severity index for cocaine use disorder and examined its predictive validity of posttreatment outcome using data from the national Drug Abuse Treatment Outcome Study. The index, based on 28 items, considered frequency of use, recency, dependency, and attempt to quit. A higher value of the index, indicating greater severity, predicted a greater likelihood of relapse (the odds ratios were 5.7 for high severity and 4.4 for medium severity, relative to low severity) and shorter time to relapse. Similarly, the polytomous logistic analysis indicated that the index predicted levels of posttreatment cocaine use (odds ratios of daily use were 47.8 for the high severity and 18.8 for medium severity; the corresponding odds ratios of weekly use were 6.75 and 5.10 and for less-than-weekly use were 3.35 and 3.57). The index can be a useful measure for both clinical and research purposes.

Entities:  

Mesh:

Year:  1999        PMID: 10665469     DOI: 10.1097/00005053-199912000-00006

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  3 in total

1.  Long term effects of cocaine on the heart assessed by cardiovascular magnetic resonance at 3T.

Authors:  Alicia M Maceira; Carmen Ripoll; Juan Cosin-Sales; Begoña Igual; Mirella Gavilan; Jose Salazar; Vicente Belloch; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2014-04-23       Impact factor: 5.364

Review 2.  Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review.

Authors:  Margaux Poireau; Thomas Milpied; Angéline Maillard; Christine Delmaire; Emmanuelle Volle; Frank Bellivier; Romain Icick; Julien Azuar; Cynthia Marie-Claire; Vanessa Bloch; Florence Vorspan
Journal:  Brain Sci       Date:  2022-07-30

3.  Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial.

Authors:  Christopher S Stauffer; Salem Samson; Alex Hickok; William F Hoffman; Steven L Batki
Journal:  Front Psychiatry       Date:  2022-01-17       Impact factor: 5.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.